How Analysts Rated Inogen Inc (NASDAQ:INGN) Last Week?

June 19, 2017 - By Adrian Erickson

 How Analysts Rated Inogen Inc (NASDAQ:INGN) Last Week?
Investors sentiment decreased to 0.9 in Q4 2016. Its down 0.54, from 1.44 in 2016Q3. It fall, as 14 investors sold Inogen Inc shares while 69 reduced holdings. 33 funds opened positions while 42 raised stakes. 20.18 million shares or 5.66% less from 21.39 million shares in 2016Q3 were reported.
Pinebridge Limited Partnership stated it has 2,019 shares. The California-based Lpl Lc has invested 0% in Inogen Inc (NASDAQ:INGN). Menta Limited Liability Company reported 0.09% of its portfolio in Inogen Inc (NASDAQ:INGN). The Kansas-based Kornitzer Capital Mgmt Ks has invested 0.21% in Inogen Inc (NASDAQ:INGN). Oppenheimer stated it has 0.02% of its portfolio in Inogen Inc (NASDAQ:INGN). Wells Fargo & Mn accumulated 283,279 shares. Ent invested in 27 shares or 0% of the stock. Swiss Retail Bank reported 26,400 shares stake. Driehaus Capital Lc owns 167,299 shares. State Street Corporation holds 0% or 368,763 shares in its portfolio. Quantbot Tech Lp invested 0% in Inogen Inc (NASDAQ:INGN). Proshare Limited Liability stated it has 0% of its portfolio in Inogen Inc (NASDAQ:INGN). Trexquant L P reported 4,100 shares. Thompson Davis & Co has 0.01% invested in Inogen Inc (NASDAQ:INGN) for 125 shares. Thomson Horstmann Bryant has invested 0.14% in Inogen Inc (NASDAQ:INGN).

Inogen Inc (NASDAQ:INGN) Ratings Coverage

Among 4 analysts covering Inogen (NASDAQ:INGN), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Inogen had 7 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of Inogen Inc (NASDAQ:INGN) earned “Buy” rating by Stifel Nicolaus on Wednesday, August 12. Stifel Nicolaus maintained it with “Buy” rating and $68.0 target in Tuesday, September 22 report. The stock of Inogen Inc (NASDAQ:INGN) has “Overweight” rating given on Wednesday, July 13 by JP Morgan. Needham maintained it with “Strong Buy” rating and $55 target in Wednesday, November 11 report. The stock of Inogen Inc (NASDAQ:INGN) has “Neutral” rating given on Thursday, March 24 by Piper Jaffray. On Wednesday, August 12 the stock rating was maintained by Leerink Swann with “Buy”. Below is a list of Inogen Inc (NASDAQ:INGN) latest ratings and price target changes.

About 57,575 shares traded. Inogen Inc (NASDAQ:INGN) has risen 88.09% since June 19, 2016 and is uptrending. It has outperformed by 71.39% the S&P500.

Inogen, Inc. is a medical technology company. The company has market cap of $1.94 billion. The Firm develops, makes and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 83.38 P/E ratio. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device.

More notable recent Inogen Inc (NASDAQ:INGN) news were published by: Zacks.com which released: “Inogen Secures New Direct-to-Consumer Business Facility” on June 05, 2017, also Nasdaq.com with their article: “Inogen (INGN) Up 8% Since Earnings Report: Can It Continue?” published on June 13, 2017, Zacks.com published: “Inogen (INGN) Hits a 52-Week High on Solid Q1, Upbeat View” on May 30, 2017. More interesting news about Inogen Inc (NASDAQ:INGN) were released by: Nasdaq.com and their article: “Inogen (INGN) Scores a Strong Buy Right Now: Here’s How” published on June 19, 2017 as well as Businesswire.com‘s news article titled: “Inogen Secures Additional Facility to Support Direct-to-Consumer Sales Growth” with publication date: June 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: